BDSX Q4 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$15M+52.7% YoY

Gross Profit

$11M77.0% margin

Operating Income

-$7M-46.7% margin

Net Income

-$9M-62.3% margin

EPS (Diluted)

$-1.98

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$15M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$99M

Total Liabilities

$95M

Stockholders' Equity

$5M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$10M	+52.7%
Gross Profit	$11M	$6M	+79.2%
Operating Income	-$7M	-$14M	+50.7%
Net Income	-$9M	-$20M	+55.1%

Revenue Segments

Diagnostic Tests

$13M100%